Nerve growth factor (Genentech)

N/A

Report date: 2024/12/18 10:01:44

Base Information

Drug NameNerve growth factor (Genentech)
Drug Alias NameNeuleze
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionNeurons stimulants
TargetsNerve growth factor receptor Trk-ANerve growth factor receptors
Therapy Area/IndicationsNeuralgiaDiabetic NeuropathiesPeripheral Nervous System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen IncGenentech IncChiron
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChironAmgen IncGenentech Inc +[4] 
Active IndicationsN/A
Inactive IndicationsNeuralgiaDiabetic NeuropathiesPeripheral Nervous System Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A